文献速递前列腺增生与排尿功能障碍

患者整体改善印象而非症状特异性改善可预测经皮胫神经刺激治疗膀胱过度活动症的持续性

Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement.
PubMed 文献 · Urology · 2020-12-21

这项前瞻性观察研究纳入90例启动经皮胫神经刺激(PTNS)治疗的膀胱过度活动症(OAB)患者,评估进展至维持期PTNS是否与患者整体改善印象(PGII)而非症状特异性改善相关。仅19%持续PTNS治疗至少1年。

要点

  • 多数完成12周诱导期的OAB患者选择继续每月PTNS维持治疗。
  • 选择维持治疗者PGII评分显著更低,而OABq-SF症状评分无显著差异。
  • 仅19%的患者持续PTNS治疗至少1年。

核心结论

  • 更多患者选择PTNS每月维持治疗而非其他疗法,且与更低的PGII评分显著相关。
  • 整体改善而非症状特异性反应可预测PTNS长期维持治疗。
  • 在追求维持治疗而非其他选择的患者中未识别出症状特异性预测因素。
  • PTNS一年持续率较低。

研究设计与样本

  • 前瞻性观察性研究,纳入90例启动PTNS治疗的OAB患者。
  • 使用PGII和OAB短问卷(OABq-SF)评估膀胱症状严重程度与改善。
  • 完成12周诱导期者可选继续每月PTNS维持或其他方案。
  • 主要结局为追求维持治疗与其他选择者之间PGII评分的差异。
  • 采用描述性统计和混合效应模型分析。

临床怎么用

  • 临床中可用PGII评估OAB患者对PTNS的整体改善感受,辅助判断是否继续维持治疗。
  • 症状特异性问卷改善不显著时,不应仅据此否定PTNS维持治疗的价值。
  • 需向患者告知PTNS一年持续率较低(19%),共同决策长期治疗计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate whether progression to maintenance percutaneous tibial nerve stimulation (PTNS) was related to perceived global impression of improvement (PGII) rather than symptom-specific improvement in patient with overactive bladder (OAB). We hypothesize that PGII will predict continuation of PTNS long-term. METHODS: This prospective observational study included 90 patients with OAB that initiated PTNS. The PGII and OAB short-form questionnaires (OABq-SF) were used to assess bladder symptom severity and improvement. Those that completed the 12-week induction phase were offered to continue PTNS monthly maintenance or pursue other options. The primary outcome was difference in PGII score between those pursuing maintenance therapy versus other options. Descriptive statistics and mixed effect modeling analysis were employed. RESULTS: Seventy patients (78%) completed 12 weeks of PTNS. The majority of completers pursued monthly maintenance (P< .01) and had significantly lower median PGII scores compared with those who sought alternatives (P < .01), while OABq-SF scores did not differ significantly (P = .65). Patients that pursued monthly PTNS maintenance had lower body mass index than those who chose alternative therapies (P < .01). Only 19% continued PTNS therapy for at least 1 year. CONCLUSION: More patients pursued PTNS monthly maintenance over any other therapy, and this was significantly associated with lower PGII scores. Global improvement, and not symptom-specific response, predicts long-term PTNS maintenance. No symptom-specific predictors were identified in those who pursued maintenance over other options. One-year continuation rates are low.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Brandon C, Oh C, Brucker BM, et al. Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement. Urology. 2020. PMID: 33358753. doi:10.1016/j.urology.2020.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。